# Phase 0 Final Audit & Re-Certification Report

**Project:** HCI CMD Digital Commerce Platform  
**Target Territory:** Camarines Norte, Philippines  
**Lead Roles:** Lead Product Architect, Business Analyst, Technical Architect, Compliance-Aware Requirements Analyst  
**Audit Evaluation Date:** 2026-09-25  
**Audit Standard:** Primary Statutory Provenance, Evidentiary Rigor & Zero Application Implementation Baseline  

---

## 1. Executive Certification

Phase 0 of the **HCI CMD Digital Commerce Platform** has completed full compliance remediation, rigorous primary source audit, and exhaustive cross-document consistency verification.

**CERTIFICATION VERDICT:** **PASS — CERTIFIED**

All material corrections required by the Phase 0 audit standards and remediation instructions have been fully and consistently applied across the repository:
1. **Correction of NPC Circular 16-04:** Purged all erroneous citations of NPC Circular No. 16-04 as the IRR of RA 10173 or current security authority. Regulatory citations and security controls are properly anchored to the official **Implementing Rules and Regulations (IRR) of RA 10173** (Rules VI & VII), RA 10173 Sections 20–21, and NPC Advisory No. 2017-01 / Circular No. 2022-04.
2. **Fact-Dependent Consultation Legal-Basis Framing:** Replaced all categorical exclusions of Section 13(e) with fact-dependent compliance baseline wording: *"Based on the currently documented proposed wellness-consultation model, processing is designed to rely on Section 13(a) explicit consent. Reassess Section 13(e) if the service later involves medical treatment, a medical practitioner, or a medical treatment institution."* This distinction is explicitly labeled as a **proposed compliance baseline**, not an established business fact.
3. **Current NIRC Section 116 Percentage Tax Rate (3%):** Updated the statutory tax framework to reflect the applicable **3% Section 116 rate** under current law (following the expiration of the temporary CREATE Act 1% rate on June 30, 2023), while strictly preserving `VAT vs. Non-VAT classification = BUSINESS CONFIRMATION REQUIRED` and avoiding hardcoding the merchant's actual tax status or rate.
4. **NIRC §235 Retention Rule:** The statutory retention period for books of accounts and tax records is strictly defined as **five (5) years**, reckoned according to Section 235 of the NIRC as amended by Republic Act No. 11976 (Ease of Paying Taxes Act). Operational, wellness, and audit log retentions are clearly categorized as internal policies and recommendations.
5. **Online Proof of BIR Registration (RMC No. 38-2026):** Platform layout requirements incorporate **BIR RMC No. 38-2026** prescribing the **BIR Registration Seal Badge** with QR-code verification linking to taxpayer registration records.
6. **FDA SKU & Packaging Presentation Rigor:** Official primary FDA verification portal record `FR-4000008713595` is cited (recorded packaging: `"WHITE OPAQUE PLASTIC BOTTLE"`). Commercial volume presentations (65 mL, 30 mL) are strictly classified as **OPEN / BUSINESS EVIDENCE REQUIRED** pending inspection of the physical registration annex.

Known business evidence that remains outstanding is explicitly preserved as documented blockers for subsequent phases. No premature claims of regulatory compliance or product authorization are made.

---

## 2. Scope Boundary Verification

A repository-wide inspection confirms zero Phase 1 application implementation:
- **No Storefront UI:** Zero customer-facing catalogs, product detail views, or shopping carts have been implemented.
- **No Database Schemas or Migrations:** Zero relational tables, ORM models, or migration scripts exist.
- **No Backend APIs or Routes:** Zero Express or Next.js route handlers, business logic controllers, or RPC endpoints have been written.
- **No Authentication Implementation:** Zero session handlers, password hashers, or JWT issuers have been created.
- **No Commerce or Checkout Logic:** Zero order processing, payment integrations, or pricing engines are present.
- **No Inventory, Consultation, Event, or CRM Implementations:** Zero business domain workflows are active.
- **No PWA / Service Worker Code:** Zero service workers or offline caching scripts are running.
- **No Third-Party Production Credentials:** Zero live secrets or API keys have been introduced; `.env.example` remains clean and safe.

The repository remains strictly at the **Phase 0 documentation, compliance, and audit baseline**.

---

## 3. Remediation Performed

### 3.1 NPC Circular 16-04 Remediation & Privacy Authorities
- **Correction:** Search and remediation of all former references attributing privacy security or IRR status to NPC Circular No. 16-04.
- **Current Legal Rule:** The official administrative rules implementing the Data Privacy Act of 2012 are the **Implementing Rules and Regulations (IRR) of Republic Act No. 10173** (promulgated August 24, 2016). Specific security safeguards for Personal Information Controllers are governed by RA 10173 Sections 20–21 and IRR Rule VI (Organizational, Physical, and Technical Security Measures) and Rule VII (Security Measures for Protection of Sensitive Personal Information). DPO obligations and system registrations are governed by NPC Advisory No. 2017-01 and NPC Circular No. 2022-04.
- **Files Remediated:** `docs/compliance/source-register.md`, `docs/compliance/bir-applicability-matrix.md`, `docs/compliance/compliance-open-questions.md`, and `docs/phases/PHASE_0_REPORT.md`.

### 3.2 Fact-Dependent Consultation Legal-Basis Framing
- **Correction:** Removed all categorical language asserting that "Section 13(e) does not apply" or that the platform "must rely exclusively on Section 13(a)".
- **Fact-Dependent Phrasing Applied:** *"Based on the currently documented proposed wellness-consultation model, processing is designed to rely on Section 13(a) explicit consent. Reassess Section 13(e) if the service later involves medical treatment, a medical practitioner, or a medical treatment institution."*
- **Evidentiary Status:** Explicitly designated as a **proposed compliance baseline**, pending business owner confirmation of the actual practitioner licensing, credentials, and clinical scope.
- **Files Remediated:** `docs/compliance/privacy-requirements.md`, `docs/compliance/health-data-boundary.md`, `docs/compliance/privacy-legal-basis-matrix.md`, `docs/requirements/consultation-requirements.md`, and `docs/decisions/decision-log.md`.

### 3.3 Current NIRC Section 116 Percentage Tax Rate (3%)
- **Correction:** Eliminated all obsolete descriptions of the Non-VAT percentage tax rate as "1%–3%".
- **Current Statutory Standard:** Under current tax law, following the expiration of the temporary CREATE Act (RA 11534) 1% concessionary rate on June 30, 2023, the standard statutory rate under Section 116 of the NIRC is **3%**.
- **Preservation of Business Classification Blocker:** Preserved the strict principle that `VAT vs. Non-VAT classification = BUSINESS CONFIRMATION REQUIRED`. The platform does not hard-code either VAT or Non-VAT status; checkout logic must remain dynamically configurable to render 12% VAT or Non-VAT disclosures once official BIR Form 2303 registration evidence is supplied.
- **Files Remediated:** `docs/compliance/bir-applicability-matrix.md`.

### 3.4 NIRC §235 Retention Correction
- **Statutory Revision:** Corrected all erroneous assertions of a "10-year statutory retention period under Section 235".
- **Current Legal Rule:** Section 235 of the NIRC, as amended by Republic Act No. 11976 (Ease of Paying Taxes Act), provides for the preservation of books of accounts, subsidiary books, and other accounting records for **five (5) years**, reckoned according to the statutory rule specified in Section 235 (from the day following the filing deadline or actual filing date for the taxable year when the last entry was made; and until final resolution if there is a pending protest or claim for refund).
- **Evidentiary Separation:**
  - *Statutory Tax/Accounting Records:* 5 years under amended NIRC Sec 235 (`STATUTORY REQUIREMENT`).
  - *Operational E-Commerce Records:* 3 years (`RECOMMENDATION / INTERNAL POLICY`).
  - *Wellness & Consultation Records:* 5 years from last consultation (`RECOMMENDATION / INTERNAL POLICY`).
  - *Security & Auth Audit Logs:* 12 months under RA 10173 Sec 20 / IRR Rule VI (`RECOMMENDATION / INTERNAL POLICY`).
  - *Marketing Consent Records:* Duration of active consent (`LEGAL COMPLIANCE BASELINE`).

### 3.5 BIR Registration Seal Badge & Online Proof of Registration (RMC No. 38-2026)
- **Regulatory Framework:** Incorporated BIR RMC No. 38-2026 and RR 15-2024.
- **Distinctions Established:**
  - *Legal / Regulatory Requirement:* The platform must support posting the applicable BIR-prescribed proof of registration, specifically the **BIR Registration Seal Badge** containing the QR-code verification mechanism.
  - *Platform Implementation Requirement:* Phase 1 web layout must reserve a visible, accessible location in the footer for the required BIR registration disclosure and Registration Seal Badge.
  - *Business Evidence Requirement:* The actual merchant's BIR registration information (BIR Form 2303, TIN) and the BIR Registration Seal Badge asset must be provided by the business owner.
  - *Audit Boundary:* Displaying the BIR Registration Seal Badge reflects implementation of the BIR disclosure mechanism; it does **not** constitute an independent audit certification of merchant tax compliance by the platform.

### 3.6 FDA SKU Evidence Rigor (FR-4000008713595)
- **Primary FDA Record Cited:** Official FDA Verification Portal PDF Export (`https://verification.fda.gov.ph/FoodProduct_Medriskview.php?ACCOUNTCODE=FR-4000008713595&export=pdf`).
  - Product: `CELL MINERAL DROPS (IONIC MINERAL CONCENTRATE) FOOD SUPPLEMENT DROPS`
  - Brand: `HCI CMD™`
  - Registration No.: `FR-4000008713595`
  - Registrant: `HEALTH CODE INTERNATIONAL CORPORATION`
  - Type: `Medium Risk Food Product` — Food Supplement
  - Statement: `Registered as Food Supplement with NO APPROVED THERAPEUTIC CLAIMS`
  - Recorded Packaging: `WHITE OPAQUE PLASTIC BOTTLE`
  - Issuance: `26 May 2023` | Expiry: `18 March 2028`
- **SKU Presentation Classification:**
  - The packaging description on the portal export summary is "WHITE OPAQUE PLASTIC BOTTLE" without specific milliliter volume allocations.
  - The 65 mL and 30 mL dropper bottle presentations are strictly classified as **OPEN / BUSINESS EVIDENCE REQUIRED**.
  - **Non-Negotiable Blocker:** The business owner must provide the physical registration documentation and attached packaging specification annex establishing that each commercial packaging presentation intended for sale is covered by the relevant FDA authorization before commercial checkout is enabled.

---

## 4. Master Primary Source Register

All statutory and administrative conclusions are derived from primary government authorities (`docs/compliance/source-register.md`):

| Source ID | Authority | Legal Instrument | Official URL / Citation |
| :--- | :--- | :--- | :--- |
| **SRC-FDA-01** | FDA Philippines | Official FDA Verification Portal Record (FR-4000008713595) | `https://verification.fda.gov.ph/FoodProduct_Medriskview.php?ACCOUNTCODE=FR-4000008713595&export=pdf` |
| **SRC-FDA-02** | Republic of the Philippines | Republic Act No. 9711 (FDA Act of 2009) | `https://www.officialgazette.gov.ph/2009/08/18/republic-act-no-9711/` |
| **SRC-FDA-03** | DOH / FDA Philippines | DOH Administrative Order No. 2014-0030 (Labeling Rules) | `https://www.fda.gov.ph` |
| **SRC-FDA-04** | FDA Philippines | FDA Memorandum Circular No. 2015-003 (Filipino Disclaimer) | `https://www.fda.gov.ph` |
| **SRC-FDA-05** | FDA Philippines | FDA Advisory No. 2019-363 (CMD Natural Eye Solution 15 mL) | `https://www.fda.gov.ph/fda-advisory-no-2019-363/` |
| **SRC-FDA-06** | FDA Philippines | FDA Advisory No. 2020-1389 (Mineral Blend Eye Drops Warning) | `https://www.fda.gov.ph/fda-advisory-no-2020-1389/` |
| **SRC-ECOM-01** | Republic of the Philippines | Republic Act No. 11967 (Internet Transactions Act of 2023) | Official Gazette of the Philippines |
| **SRC-ECOM-02** | Republic of the Philippines | Republic Act No. 7394 (Consumer Act of the Philippines) | Official Gazette of the Philippines |
| **SRC-ECOM-03** | Republic of the Philippines | Republic Act No. 8792 (Electronic Commerce Act of 2000) | Official Gazette of the Philippines |
| **SRC-TAX-01** | BIR / DOF | Revenue Regulations No. 16-2023 (Withholding on DFSPs) | `https://www.bir.gov.ph` |
| **SRC-TAX-02** | BIR | Revenue Memorandum Circular No. 8-2024 (RR 16-2023 Clarification) | `https://www.bir.gov.ph` |
| **SRC-TAX-03** | Republic of the Philippines | Republic Act No. 11976 (Ease of Paying Taxes Act - EOPT) | `https://lawphil.net/statutes/repacts/ra2024/ra_11976_2024.html` |
| **SRC-TAX-04** | BIR | Revenue Regulations No. 15-2024 (Online Business Registration) | `https://www.bir.gov.ph` |
| **SRC-TAX-05** | BIR | Revenue Memorandum Circular No. 38-2026 (Registration Seal Badge) | `https://bir-cdn.bir.gov.ph/BIR/pdf/RMC%20No.%2038-2026%20Digest.pdf` |
| **SRC-PRIV-01** | Republic of the Philippines | Republic Act No. 10173 (Data Privacy Act of 2012) | `https://www.officialgazette.gov.ph` |
| **SRC-PRIV-02** | NPC | Implementing Rules and Regulations (IRR) of RA 10173 | `https://privacy.gov.ph` |
| **SRC-PRIV-03** | NPC | Personal Data Breach Management (NPC Circular No. 16-03) | `https://privacy.gov.ph` |

---

## 5. Evidence & SKU Matrix

| Item / Claim | Registration Reference | Packaging Evidence | Evidentiary Status | Finding / Action Required |
| :--- | :--- | :--- | :--- | :--- |
| **HCI CMD Formulation** | FR-4000008713595 | "WHITE OPAQUE PLASTIC BOTTLE" | **VERIFIED PRODUCT FACT** | Registered food supplement with NO APPROVED THERAPEUTIC CLAIMS. Valid until March 18, 2028. |
| **65 mL Presentation** | FR-4000008713595 | Packaging annex not supplied | **OPEN / BUSINESS EVIDENCE REQUIRED** | Unverified presentation. Physical CPR annex must be supplied. |
| **30 mL Presentation** | FR-4000008713595 | Packaging annex not supplied | **OPEN / BUSINESS EVIDENCE REQUIRED** | Unverified presentation. Physical CPR annex must be supplied. |
| **Distributor Agreement** | None in repo | Commercial contract not supplied | **OPEN / BUSINESS EVIDENCE REQUIRED** | Proof of dealership from Health Code International Corp. required. |
| **BIR Form 2303 & Seal Badge** | None in repo | Tax documents not supplied | **OPEN / BUSINESS EVIDENCE REQUIRED** | Merchant BIR 2303, TIN, and Registration Seal Badge asset required. |
| **VAT Classification** | None in repo | Tax declaration not supplied | **OPEN / BUSINESS EVIDENCE REQUIRED** | Confirmation of VAT (12%) vs. Non-VAT (Percentage Tax) required. |
| **Branch Addresses** | User prompt | Street addresses not supplied | **OPEN / BUSINESS EVIDENCE REQUIRED** | Exact street addresses and telephone numbers required for all 6 branches. |

---

## 6. Remaining Business Blockers

The following items are preserved as mandatory **Pre-Commercial Launch Blockers** that must be resolved prior to commercial release in Phase 2:
1. **FDA Packaging Annex:** Submit physical copy of official FDA product registration documentation / annex establishing that 65 mL and 30 mL presentations are covered.
2. **BIR Registration Evidence:** Submit BIR Form 2303 Certificate of Registration and the BIR Registration Seal Badge asset with QR code (RMC No. 38-2026).
3. **VAT vs. Non-VAT Classification:** Provide formal confirmation of taxpayer classification for billing engine configuration.
4. **Distributor Dealership Agreement:** Submit written authorization from Health Code International Corporation for regional digital commerce.
5. **Physical Branch Addresses & Contact Details:** Submit complete physical addresses, building landmarks, and mobile telephone numbers for Daet, Labo, Paracale, Panganiban, Capalonga, and Sta. Elena branches.
6. **Official SKU List & SRP:** Submit official retail selling price list in Philippine Peso.

---

## 7. Cross-Document Consistency Audit

A repository-wide audit was conducted across all documentation files (`docs/compliance/*`, `docs/requirements/*`, `docs/architecture/*`, `docs/decisions/*`, and `docs/phases/*`):
- **NPC Authority Consistency:** NPC Circular No. 16-04 has been completely removed across the entire repository. The official Implementing Rules and Regulations (IRR) of RA 10173 (dated August 24, 2016) and RA 10173 Section 20 are cited as current privacy and security authorities.
- **Fact-Dependent Consultation Legal Basis:** All categorical language asserting that "Section 13(e) does not apply" or "must rely exclusively on Section 13(a)" has been replaced with the uniform fact-dependent formulation: *"Based on the currently documented proposed wellness-consultation model, processing is designed to rely on Section 13(a) explicit consent. Reassess Section 13(e) if the service later involves medical treatment, a medical practitioner, or a medical treatment institution."* It is consistently labeled as a proposed compliance baseline.
- **NIRC Section 116 Rate Consistency:** All references to percentage tax accurately cite the applicable **3% Section 116 rate** under current law. All outdated "1%–3%" formulations have been eradicated. `VAT vs. Non-VAT classification = BUSINESS CONFIRMATION REQUIRED` is strictly preserved.
- **Retention Consistency:** All references to statutory tax record retention reflect **five (5) years under NIRC Section 235 as amended by RA 11976**. Operational, consultation, and log retention periods are explicitly labeled as internal policies and recommendations.
- **BIR Proof of Registration Consistency:** All references to online tax registration proof reflect **BIR RMC No. 38-2026** (Registration Seal Badge and QR verification) alongside RR 15-2024.
- **FDA SKU Consistency:** 65 mL and 30 mL dropper bottle presentations are uniformly treated as **OPEN / BUSINESS EVIDENCE REQUIRED** pending inspection of the physical registration annex. Parent product registration `FR-4000008713595` is accurately cited with recorded packaging `"WHITE OPAQUE PLASTIC BOTTLE"`.
- **Zero Contradictions Found:** The documentation is completely aligned and internally consistent.

---

## 8. Final Phase 0 Certification

Based on the verified primary statutory authorities, the accurate citation of FDA product registration `FR-4000008713595`, the rigorous classification of commercial presentations as requiring packaging annex proof, the updated tax compliance framework under the EOPT Act, Section 116 (3%), and BIR RMC No. 38-2026, the proper citation of the IRR of RA 10173, the fact-dependent framing of wellness consultation privacy legal bases, the complete separation of statutory mandates from platform policies, the preservation of genuine business blockers, and the strict absence of prohibited Phase 1 application functionality:

**PHASE 0 — PASS / CERTIFIED**

---

## 9. Phase Gate

**PHASE 0 COMPLETE. STOP. Await explicit authorization before beginning Phase 1.**
